KV Pharma seeks Chapter 11 bankruptcy protection - Boston.com

08/06/12

KV Pharma seeks Chapter 11 bankruptcy protection
Boston.com
NEW YORK (AP) — K-V Pharmaceutical Co. has filed filing for Chapter 11 bankruptcy protection as it deals with weak sales, a payment related to its costly preterm birth drug Makena, and sanctions related to past manufacturing problems. The St. Louis ...
KV Pharmaceutical Files for Chapter 11Wall Street Journal
News Summary: KV Pharma files Chapter 11Businessweek

all 133 news articles »

[more]